<VariationArchive VariationID="635277" VariationName="NM_002294.3(LAMP2):c.190_191del (p.Val64fs)" VariationType="Deletion" Accession="VCV000635277" Version="8" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-14" DateCreated="2019-07-01" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="623111" VariationID="635277">
      <GeneList>
        <Gene Symbol="LAMP2" FullName="lysosomal associated membrane protein 2" GeneID="3920" HGNC_ID="HGNC:6501" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq24</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="120426148" stop="120469349" display_start="120426148" display_stop="120469349" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="119560002" stop="119603203" display_start="119560002" display_stop="119603203" Strand="-" />
          </Location>
          <OMIM>309060</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LAMP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LAMP2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002294.3(LAMP2):c.190_191del (p.Val64fs)</Name>
      <CanonicalSPDI>NC_000023.11:120455562:ACA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq24</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="120455563" stop="120455564" display_start="120455563" display_stop="120455564" variantLength="2" positionVCF="120455562" referenceAlleleVCF="TAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="119589418" stop="119589419" display_start="119589418" display_stop="119589419" variantLength="2" positionVCF="119589417" referenceAlleleVCF="TAC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>V64fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_749" sequenceAccession="LRG_749">
            <Expression>LRG_749:g.18786_18787del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_749t3" sequenceAccession="LRG_749t3">
            <Expression>LRG_749t3:c.190_191del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_749p3" sequenceAccession="LRG_749p3" change="p.Val64fs">
            <Expression>LRG_749p3:p.Val64fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_749t1" sequenceAccession="LRG_749t1">
            <Expression>LRG_749t1:c.190_191del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_749p1" sequenceAccession="LRG_749p1" change="p.Val64fs">
            <Expression>LRG_749p1:p.Val64fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_749t2" sequenceAccession="LRG_749t2">
            <Expression>LRG_749t2:c.190_191del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_749p2" sequenceAccession="LRG_749p2" change="p.Val64fs">
            <Expression>LRG_749p2:p.Val64fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.119589419_119589420del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.119589419_119589420del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.120455564_120455565del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.120455564_120455565del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007995.1" sequenceAccession="NG_007995" sequenceVersion="1" change="g.18786_18787del">
            <Expression>NG_007995.1:g.18786_18787del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122606.1" sequenceAccession="NM_001122606" sequenceVersion="1" change="c.190_191del">
            <Expression>NM_001122606.1:c.190_191del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116078.1" sequenceAccession="NP_001116078" sequenceVersion="1" change="p.Val64fs">
            <Expression>NP_001116078.1:p.Val64fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002294.3" sequenceAccession="NM_002294" sequenceVersion="3" change="c.190_191del" MANESelect="true">
            <Expression>NM_002294.3:c.190_191del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002285.1" sequenceAccession="NP_002285" sequenceVersion="1" change="p.Val64fs">
            <Expression>NP_002285.1:p.Val64fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013995.2" sequenceAccession="NM_013995" sequenceVersion="2" change="c.190_191del">
            <Expression>NM_013995.2:c.190_191del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_054701.1" sequenceAccession="NP_054701" sequenceVersion="1" change="p.Val64fs">
            <Expression>NP_054701.1:p.Val64fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1569371330" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002294.3(LAMP2):c.190_191del (p.Val64fs) AND Danon disease" Accession="RCV000786769" Version="8">
        <ClassifiedConditionList TraitSetID="2823">
          <ClassifiedCondition DB="MedGen" ID="C0878677">Danon disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-09" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-09" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-07-01" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21415759</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23955649</ID>
        </Citation>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-11-27">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="2823" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1699" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycogen Storage Disease Type IIb</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vacuolar cardiomyopathy and myopathy X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Antopol disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pseudoglycogenosis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease limited to the heart</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage cardiomyopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 2b (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lysosomal glycogen storage disease without acid maltase deficiency (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD2B (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PSEUDOGLYCOGENOSIS II</ElementValue>
                <XRef Type="MIM" ID="300257" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD IIb</ElementValue>
                <XRef Type="MIM" ID="300257" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="300257" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Danon disease</ElementValue>
                <XRef ID="Danon+Disease/2114" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010281" DB="MONDO" />
                <XRef ID="419097006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GSD2B</ElementValue>
                <XRef Type="MIM" ID="300257" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Danon disease is a multisystem condition with predominant involvement of the heart, skeletal muscles, and retina, with overlying cognitive dysfunction. Males are typically more severely affected than females. Males usually present with childhood onset concentric hypertrophic cardiomyopathy that is progressive and often requires heart transplantation. Rarely, hypertrophic cardiomyopathy can evolve to resemble dilated cardiomyopathy. Most affected males also have cardiac conduction abnormalities. Skeletal muscle weakness may lead to delayed acquisition of motor milestones. Learning disability and intellectual disability, most often in the mild range, are common. Additionally, affected males can develop retinopathy with subsequent visual impairment. The clinical features in females are broader and more variable. Females are more likely to have dilated cardiomyopathy, with a smaller proportion requiring heart transplantation compared to affected males. Cardiac conduction abnormalities, skeletal muscle weakness, mild cognitive impairment, and pigmentary retinopathy are variably seen in affected females.</Attribute>
                <XRef ID="NBK554742" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9730" />
                <XRef ID="9730" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173338</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">32134616</ID>
                <ID Source="BookShelf">NBK554742</ID>
              </Citation>
              <XRef ID="34587" DB="Orphanet" />
              <XRef ID="C0878677" DB="MedGen" />
              <XRef ID="MONDO:0010281" DB="MONDO" />
              <XRef Type="MIM" ID="300257" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1809305" SubmissionDate="2019-06-28" DateLastUpdated="2019-07-01" DateCreated="2019-07-01">
        <ClinVarSubmissionID localKey="SUB5871464" submittedAssembly="GRCh37" title="SUB5871464" />
        <ClinVarAccession Accession="SCV000924630" DateUpdated="2019-07-01" DateCreated="2019-07-01" Type="SCV" Version="1" SubmitterName="Cytoplasmic Inheritance Laboratory, Institute of Genetics and Cytology" OrgID="507052" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment Type="public">The variant is absent in publicly available population databases (gnomAD, 1000Genomes). It was found in a woman with dilatation cardiomyopathy. NM_002294.2:c.190_191delAC creates a premature stop codon at position 11 of the new reading frame - p.V64NfsX11. It means the truncated protein lacks the transmembrane domain, cytosolic tail and most part of the luminal domain. Such rearrangement will lead to loss of function of LAMP2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>European Caucasoid</Ethnicity>
              <GeographicOrigin>Belarus</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <Comment Type="public">The ECG showed a high voltage of complexes, WPW signs. MRI confirmed dilatation of the heart cavities, reduction of LV contractility and intramural linear fibrosis of the LV myocardium. The thickness of the RV and LV myocardium was 6-8 mm and 7-9 mm respectively. Laboratory testing during this period confirmed consistently elevated serum N-terminal brain natriuretic propeptide, alanine aminotransferase, lactate dehydrogenase levels. All other serum parameters were normal as well as creatine phosphokinase. The physical examination revealed no specific abnormalities, especially no muscle weakness.</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMP2">
              <Name>lysosomal associated membrane protein 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_002294.2:exon 3</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002294.2:c.190_191del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300257" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5871464</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4252684" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4978329|MedGen:C0878677" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002236776" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23955649</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21415759</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 635277). This premature translational stop signal has been observed in individual(s) with Danon disease (PMID: 23955649). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val64Asnfs*11) in the LAMP2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMP2 are known to be pathogenic (PMID: 21415759). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.119589418_119589419del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0878677" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1809305" TraitType="Disease" MappingType="XRef" MappingValue="300257" MappingRef="OMIM">
        <MedGen CUI="C0878677" Name="Danon disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4252684" TraitType="Disease" MappingType="XRef" MappingValue="C0878677" MappingRef="MedGen">
        <MedGen CUI="C0878677" Name="Danon disease" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002017088</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

